FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313530127> ?p ?o ?g. }

• W4313530127 endingPage "115033" @default.
• W4313530127 startingPage "115033" @default.
• W4313530127 abstract "Social cognitive and negative symptoms impairment may increase the risk of mental disability in individuals with schizophrenia. However, randomized controlled studies on the effectiveness of accelerated intermittent theta burst stimulation (iTBS) for social cognition and negative symptoms in individuals with schizophrenia are very limited.A total of 125 individuals with schizophrenia were recruited, 66 of whom were randomly divided into an active iTBS group (n=34) and sham iTBS group (n=32) by stratified sampling. Participants received either active iTBS or sham iTBS targeting the left dorsolateral prefrontal cortex (DLPFC) 20 sessions for 4 weeks under navigation. The Facial Emotion Recognition Test (FERT), Hinting Task (HT), and Positive and Negative Syndrome Scale (PANSS) were measured at baseline, 2 weeks, and 4 weeks. The trial protocol was registered with the Chinese Clinical Trial Registry (ChiCTR2100051984).Sixty patients (90.90%) completed the intervention and the 4-week follow-up, including 29 women (43.94%) and 37 men (56.06%) with a mean (SD) age of 47.53 (10.17) years. The primary outcomes showed FERT scores (week 2; 0.27 [95% CI, 0.09 to 0.45]; P< .01; ES 0.14) (week 4; 0.63 [95% CI, 0.45 to 0.80]; P< .001; ES 0.47) and HT scores (week 2; 1.00 [95% CI, -0.02 to 1.98]; P< .05; ES 0.67) (week 4; 2.13 [95% CI, 1.21 to 3.06]; P< .001; ES 0.27) in the active iTBS group were significantly different from those in the sham iTBS group at 2 and 4 weeks of follow-up. The secondary outcome showed that the negative symptom score (-3.43 [95% CI, -4.85 to -2.01]; P< .001; ES 0.29) of the active iTBS group was significantly different from that of the sham iTBS group at the 4th week of follow-up.Accelerated iTBS can effectively ameliorate the social cognition and negative symptoms of individuals with schizophrenia. These results suggest that accelerated iTBS may be a safe and effective neuromodulation technique to improve the overall functional recovery of individuals with schizophrenia, and has a good clinical application prospect." @default.
• W4313530127 created "2023-01-06" @default.
• W4313530127 creator A5029937818 @default.
• W4313530127 creator A5034259536 @default.
• W4313530127 creator A5040768034 @default.
• W4313530127 creator A5054833827 @default.
• W4313530127 creator A5065049835 @default.
• W4313530127 creator A5066058965 @default.
• W4313530127 creator A5068446469 @default.
• W4313530127 creator A5070155047 @default.
• W4313530127 creator A5089450363 @default.
• W4313530127 date "2023-02-01" @default.
• W4313530127 modified "2023-10-01" @default.
• W4313530127 title "Effectiveness of accelerated intermittent theta burst stimulation for social cognition and negative symptoms among individuals with schizophrenia: A randomized controlled trial" @default.
• W4313530127 cites W1583481107 @default.
• W4313530127 cites W1867182047 @default.
• W4313530127 cites W1969605556 @default.
• W4313530127 cites W1978530219 @default.
• W4313530127 cites W1980770127 @default.
• W4313530127 cites W1982441373 @default.
• W4313530127 cites W1988402105 @default.
• W4313530127 cites W2013664730 @default.
• W4313530127 cites W2032431774 @default.
• W4313530127 cites W2036630871 @default.
• W4313530127 cites W2038093063 @default.
• W4313530127 cites W2038662568 @default.
• W4313530127 cites W2045106504 @default.
• W4313530127 cites W2072677461 @default.
• W4313530127 cites W2080247792 @default.
• W4313530127 cites W2088168551 @default.
• W4313530127 cites W2104637155 @default.
• W4313530127 cites W2110693992 @default.
• W4313530127 cites W2118414273 @default.
• W4313530127 cites W2125948416 @default.
• W4313530127 cites W2129217681 @default.
• W4313530127 cites W2140606211 @default.
• W4313530127 cites W2145066872 @default.
• W4313530127 cites W2150916403 @default.
• W4313530127 cites W2153240993 @default.
• W4313530127 cites W2157160015 @default.
• W4313530127 cites W2217656301 @default.
• W4313530127 cites W2271204888 @default.
• W4313530127 cites W2337709795 @default.
• W4313530127 cites W2522888539 @default.
• W4313530127 cites W2568412142 @default.
• W4313530127 cites W2793193004 @default.
• W4313530127 cites W2801280679 @default.
• W4313530127 cites W2802696191 @default.
• W4313530127 cites W2912578203 @default.
• W4313530127 cites W2944611832 @default.
• W4313530127 cites W2957311488 @default.
• W4313530127 cites W2999794282 @default.
• W4313530127 cites W3006940803 @default.
• W4313530127 cites W3041847963 @default.
• W4313530127 cites W3091608900 @default.
• W4313530127 cites W3097964601 @default.
• W4313530127 cites W3128976787 @default.
• W4313530127 cites W3170814122 @default.
• W4313530127 cites W3172214057 @default.
• W4313530127 cites W3200053644 @default.
• W4313530127 cites W4252068617 @default.
• W4313530127 cites W4281256360 @default.
• W4313530127 cites W4283819350 @default.
• W4313530127 cites W4292104392 @default.
• W4313530127 cites W4293722138 @default.
• W4313530127 cites W4296137831 @default.
• W4313530127 cites W4302762767 @default.
• W4313530127 cites W4376453267 @default.
• W4313530127 doi "https://doi.org/10.1016/j.psychres.2022.115033" @default.
• W4313530127 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36603383" @default.
• W4313530127 hasPublicationYear "2023" @default.
• W4313530127 type Work @default.
• W4313530127 citedByCount "0" @default.
• W4313530127 crossrefType "journal-article" @default.
• W4313530127 hasAuthorship W4313530127A5029937818 @default.
• W4313530127 hasAuthorship W4313530127A5034259536 @default.
• W4313530127 hasAuthorship W4313530127A5040768034 @default.
• W4313530127 hasAuthorship W4313530127A5054833827 @default.
• W4313530127 hasAuthorship W4313530127A5065049835 @default.
• W4313530127 hasAuthorship W4313530127A5066058965 @default.
• W4313530127 hasAuthorship W4313530127A5068446469 @default.
• W4313530127 hasAuthorship W4313530127A5070155047 @default.
• W4313530127 hasAuthorship W4313530127A5089450363 @default.
• W4313530127 hasBestOaLocation W43135301271 @default.
• W4313530127 hasConcept C118552586 @default.
• W4313530127 hasConcept C126322002 @default.
• W4313530127 hasConcept C15744967 @default.
• W4313530127 hasConcept C168563851 @default.
• W4313530127 hasConcept C169900460 @default.
• W4313530127 hasConcept C2776412080 @default.
• W4313530127 hasConcept C2778528637 @default.
• W4313530127 hasConcept C2779727114 @default.
• W4313530127 hasConcept C2780135775 @default.
• W4313530127 hasConcept C2780442968 @default.
• W4313530127 hasConcept C2780508717 @default.
• W4313530127 hasConcept C2781195155 @default.
• W4313530127 hasConcept C71924100 @default.
• W4313530127 hasConceptScore W4313530127C118552586 @default.

• next